Scarica l'app Stockscreener
265.79
0.48%
1.27
Dopo l'orario di chiusura:
265.32
-0.47
-0.18%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ABBV Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$264.52
Aprire:
$264.5
Volume 24 ore:
3.67M
Relative Volume:
0.57
Capitalizzazione di mercato:
$469.68B
Reddito:
$62.82B
Utile/perdita netta:
$3.60B
Rapporto P/E:
131.10
EPS:
2.0274
Flusso di cassa netto:
$19.98B
1 W Prestazione:
+2.65%
1M Prestazione:
+2.48%
6M Prestazione:
+17.13%
1 anno Prestazione:
+28.11%
Intervallo 1D:
$263.02
$266.90
Intervallo di 1 settimana:
$259.55
$266.96
Portata 52W:
$190.75
$267.47
Abbvie Inc Stock (ABBV) Company Profile
Nome
Abbvie Inc
Settore
Industria
Telefono
(847) 932-7900
Indirizzo
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
Compare ABBV vs LLY, JNJ, MRK, NVS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
265.79 | 462.68B | 62.82B | 3.60B | 19.98B | 2.0274 |
LLY
Lilly Eli Co
|
1,233.66 | 1.11T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
273.14 | 644.33B | 97.93B | 21.04B | 17.80B | 8.6278 |
MRK
Merck Co Inc
|
156.45 | 367.58B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
159.98 | 296.97B | 54.66B | 13.58B | 16.05B | 7.0171 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-30 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2026-04-21 | Iniziato | Canaccord Genuity | Buy |
| 2026-02-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-02-20 | Iniziato | Barclays | Overweight |
| 2026-01-08 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2026-01-07 | Ripresa | UBS | Neutral |
| 2025-12-10 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-11-04 | Downgrade | DZ Bank | Buy → Hold |
| 2025-10-14 | Downgrade | Erste Group | Buy → Hold |
| 2025-10-01 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-09-17 | Aggiornamento | Berenberg | Hold → Buy |
| 2025-08-12 | Ripresa | Piper Sandler | Overweight |
| 2025-08-07 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-10 | Ripresa | BofA Securities | Neutral |
| 2024-12-05 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | Iniziato | Wolfe Research | Outperform |
| 2024-11-04 | Aggiornamento | Argus | Hold → Buy |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-06-05 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-05-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-01-29 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | Downgrade | HSBC Securities | Buy → Hold |
| 2023-12-11 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-10-30 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Ripresa | UBS | Neutral |
| 2023-09-29 | Iniziato | Raymond James | Outperform |
| 2023-07-25 | Iniziato | William Blair | Mkt Perform |
| 2023-07-14 | Iniziato | HSBC Securities | Buy |
| 2023-04-05 | Downgrade | Argus | Buy → Hold |
| 2023-03-01 | Iniziato | Guggenheim | Buy |
| 2023-02-22 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | Aggiornamento | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-11-08 | Downgrade | Societe Generale | Buy → Hold |
| 2022-08-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | Iniziato | SVB Leerink | Underperform |
| 2022-05-06 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2022-02-28 | Downgrade | UBS | Buy → Neutral |
| 2022-02-03 | Reiterato | BMO Capital Markets | Outperform |
| 2022-02-03 | Reiterato | Barclays | Equal Weight |
| 2022-02-03 | Reiterato | BofA Securities | Neutral |
| 2022-02-03 | Reiterato | Goldman | Neutral |
| 2022-01-13 | Iniziato | Redburn | Buy |
| 2022-01-12 | Reiterato | BMO Capital Markets | Outperform |
| 2021-12-09 | Ripresa | Wells Fargo | Overweight |
| 2021-11-23 | Aggiornamento | Societe Generale | Hold → Buy |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-06-23 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Aggiornamento | Argus | Hold → Buy |
| 2020-05-18 | Ripresa | BofA/Merrill | Neutral |
| 2020-05-12 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-05-11 | Ripresa | Morgan Stanley | Overweight |
| 2020-04-20 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | Downgrade | Societe Generale | Buy → Hold |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-02-06 | Iniziato | Mizuho | Buy |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | Reiterato | Cowen | Outperform |
| 2019-09-26 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-08-20 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-04-29 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
Mostra tutto
Abbvie Inc Borsa (ABBV) Ultime notizie
AbbVie (NYSE:ABBV) Large-Cap Healthcare Strategy Gains Attention - Kalkine Media
Most Of What Moves AbbVie Stock Has Nothing To Do With The Market - Trefis
AbbVie (ABBV) Presented New Lung Cancer Clinical Data At WCLC 2026 - Yahoo Finance
AbbVie Presents New Data Across Lung Cancer Pipeline At WCLC 2026 - marketscreener.com
AbbVie to Present New Data at WCLC 2026 Showcasing Innovation Across Lung Cancer Pipeline - Investing News Network
AbbVie presents lung cancer data at WCLC 2026 conference By Investing.com - Investing.com Canada
AbbVie will present 90% lung cancer response data; the treatment remains investigational - Stock Titan
AbbVie Stock's Uncoupled Performance - Trefis
Jennison Associates LLC Trims Stake in AbbVie Inc. $ABBV - MarketBeat
Oppenheimer & Co. Inc. Acquires 5,934 Shares of AbbVie Inc. $ABBV - MarketBeat
Hodges Capital Management Inc. Has $4.94 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead - The Motley Fool
Dividend Giants Pfizer, Chevron, AbbVie: Bold 2027 Price Targets Ahead - AOL.com
Vest Financial LLC Sells 3,946 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie stock hits fresh 52-week high as earnings strength and guidance lift outlook - Ad-hoc-news.de
AbbVie Inc. $ABBV Shares Sold by D.A. Davidson & CO. - MarketBeat
Benjamin Edwards Inc. Reduces Position in AbbVie Inc. $ABBV - MarketBeat
GUBRA: Biotech revenue normalized post-AbbVie deal; CRO rebounded with 11% growth and profitability - TradingView
GUBRA: Revenue fell after last year's AbbVie deal, but clinical and CRO progress support long-term growth - TradingView
AbbVie (ABBV) Earnings Report: EPS Does Not Reach the Reported Estimate in the Current Update; Stock Move: The Stock Gains 2.72%Cost Structure Review - Vinanet
AbbVie Raises $9 Billion Debt to Fund Acquisition - The Globe and Mail
AbbVie (NYSE:ABBV) Shares Up 2.6%What's Next? - MarketBeat
Is AbbVie Stock About To Break Out Again? - Yahoo Finance
HARMONY ASSET MANAGEMENT LLC's AbbVie Inc(ABBV) Holding History - GuruFocus
Billionaire Ken Griffin Increased His Position in This Dividend King by 547% - Yahoo Finance
Munich Reinsurance Co Stock Corp in Munich Has $39.59 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Insider Selling: AbbVie (NYSE:ABBV) EVP Sells 32,710 Shares - MarketBeat
AbbVie stock holds firm after Q2 revenue beat - Ad-hoc-news.de
Is AbbVie Inc (ABBV) Overvalued After 3.4% Rally? GF Value Says - GuruFocus
AbbVie Completes $10 Billion Senior Notes Offering to Support Apogee Therapeutics Acquisition - Kalkine Media
AbbVie completes $8.0 billion notes offering to support Apogee Therapeutics acquisition - Investing.com
AbbVie (NYSE:ABBV) Trading Up 3.5%Still a Buy? - MarketBeat
Form 8K AbbVie Inc For: 18 August By Investing.com - Investing.com Nigeria
AbbVie completes $8.75B note offering to fund Apogee acquisition - TradingView
AbbVie (NYSE: ABBV) issues new senior notes with Apogee-linked redemption - Stock Titan
AbbVie Inc. stock outperforms competitors on strong trading day - MarketWatch
AbbVie Inc Stock (ABBV) Closed Up by 3.48% on Aug 18: Key Drivers Unveiled - TradingKey
Revance hires Janelle Wichmann as chief marketing officer of skincare unit - Fierce Pharma
AbbVie Announces 2026 AbbVie Immunology Scholarship Recipients, Celebrating 10 Years of Support - Investing News Network
AbbVie Inc. $ABBV Shares Sold by Capital Investment Advisory Services LLC - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by ABN Amro Investment Solutions - MarketBeat
Abundance Wealth Counselors Boosts Holdings in AbbVie Inc. $ABBV - MarketBeat
Wells Fargo raises Abbvie stock price target on HS drug potential - Investing.com Canada
Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026? - AOL.com
Wells Fargo Adjusts Price Target on AbbVie to $300 From $295, Keeps Overweight Rating - marketscreener.com
AbbVie Inc. (ABBV) Stock Analysis: Navigating Growth With A 10.74% Potential Upside - DirectorsTalk Interviews
Is AbbVie Stock a Buy After Posting Strong Q2 Earnings? - AOL.com
AbbVie Inc. $ABBV Shares Bought by Exchange Traded Concepts LLC - MarketBeat
Bellecapital International Ltd. Acquires 8,728 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Confluence Wealth Services Inc. - MarketBeat
Neuroscience Is Becoming AbbVie's Quiet Powerhouse -- and Management Now Sees $12.7 Billion in Sales This Year - AOL.com
Abbvie Inc Azioni (ABBV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.84%
0.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):